Chelsea Therapeutics Announces Update to Northera (Droxidopa) NDA Filing

barbara.lempert CHARLOTTE, N.C., July 29, 2013 (GLOBE NEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration ...

Seattle Genetics Reports Second Quarter 2013 Financial Results

barbara.lempert -Total Revenues of $ 73.6 Million, Including $ 35.7 Million in ADCETRIS® (Brentuximab Vedotin) Net Product Sales- -Company Executing on Broad ADCETRIS Clinical ...
Page 38 of 38« First...102030...3435363738
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS